While the frequency of CD39+ cells in the peripheral blood is typically low in both healthy donors and cancer patients, an increased expression has been described for tumor-infiltrating CD8+ T cells [69, 70] and hepatitis C virus (HCV)- and HIV-specific CD8+ T cells [71]. Here, ENTPD1 is linked to neoplasm.